Patents by Inventor Mark Hamrick

Mark Hamrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR INHIBITING IDO1
    Publication number: 20240150311
    Abstract: Provided herein are compounds that inhibit IDO1 and methods of use thereof. Also provided are pharmaceutical compositions and medicaments that include the compounds described herein as well as methods of treating sarcopenia or age-related muscle loss.
    Type: Application
    Filed: December 15, 2023
    Publication date: May 9, 2024
    Inventors: Mark Hamrick, Carlos Isales, Iryna Lebedyeva
  • Compositions and methods for inhibiting IDO1
    Patent number: 11858908
    Abstract: Provided herein are compounds that inhibit IDO1 and methods of use thereof. Also provided are pharmaceutical compositions and medicaments that include the compounds described herein as well as methods of treating sarcopenia or age-related muscle loss.
    Type: Grant
    Filed: January 19, 2022
    Date of Patent: January 2, 2024
    Assignee: Augusta University Research Institute, Inc.
    Inventors: Mark Hamrick, Carlos Isales, Iryna Lebedyeva
  • COMPOSITIONS AND METHODS FOR INHIBITING IDO1
    Publication number: 20220227727
    Abstract: Provided herein are compounds that inhibit IDO1 and methods of use thereof. Also provided are pharmaceutical compositions and medicaments that include the compounds described herein as well as methods of treating sarcopenia or age-related muscle loss.
    Type: Application
    Filed: January 19, 2022
    Publication date: July 21, 2022
    Inventors: Mark Hamrick, Carlos Isales, Iryna Lebedyeva
  • Compositions and Methods for Treating Muscle Loss
    Publication number: 20190224166
    Abstract: Compositions of indoleamine 2,3-dioxygenase (“IDO”) inhibitors and methods of use thereof are provided. The disclosed compositions may be used to inhibit or reduce kynurenine production in the blood, treat or prevent muscle loss, increase or maintain muscle mass, muscle strength and/or muscle function, and treat or prevent sarcopenia.
    Type: Application
    Filed: January 22, 2019
    Publication date: July 25, 2019
    Inventors: Mark Hamrick, Helen Kaiser